I had some requests from a couple of my readers recently to take a closer look at small drugmaker called Antares Pharma Inc. (ATRS), and give some opinions about the operation. One of our other authors, Mark …
Seeking Alpha · 1 day ago
Antares Pharma
A promoters group of Neelkanth Technologies has made an open offer for the shareholders atRs 10 per share. The stock is trading at Rs 11.70. The open offer was triggered after the preferential allotments. The shares of …
Economic Times · 11/25/2015
retail investors
Sales for the quarter, atRs. 6,803cr (V/sRs. 6,600cr estimated ... 26.9 over FY2015–17E. We recommend a Buy on the stock.
Money Control · 11/19/2015
Sun Pharma
More from Bing News
Antares Pharma (NASDAQ:ATRS) was downgraded by Zacks from a “buy” rating to a “sell” rating in a research report issued to clients and investors on Tuesday, Market Beat Ratings reports. According to Zacks, “Antares Pharma, Inc. develops ... · 11/12/2015
Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >> ANTARES PHARMA INC (ATRS): Free Stock Analysis Report BIO REFERENCE LABS INC NEW (BRLI): Free Stock Analysis Report MILESTONE SCIENTIFIC …
Yahoo Finance · 6/25/2014
ATRS's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 30.58%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much ...
The Street · ByLaurie Kulikowski · 6/4/2015
Shares of Antares Pharma (NASDAQ:ATRS) traded up 7.52% during midday trading on Friday, reaching $1.43. The company had a trading volume of 681,181 shares. Antares Pharma has a 1-year low of $1.22 and a 1-year high of $3.04. The stock’s market ...
Intercooler · 11/6/2015
Antares Pharma Inc. (NASDAQ: ATRS) saw a big move last session, as the company's shares fell by over 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent …
Benzinga · 6/25/2014
Following the acquisition, Roche Jr. owns 38,172 shares of the company. Antares Pharma Inc (NASDAQ:ATRS)’s stock performance has been poor in 2015, decreasing by 27.24% year-to-date. However, on Wednesday, the stock rose by 3.31% to $1.87.